Financials Accent Microcell Limited

Equities

ACCENTMIC

INE0Q5D01013

Pharmaceuticals

Market Closed - NSE India S.E. 05:13:53 14/06/2024 pm IST 5-day change 1st Jan Change
286 INR -2.59% Intraday chart for Accent Microcell Limited +4.30% -2.17%

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales 1 953 1,140 1,314 1,368 1,718 2,042
EBITDA 1 111.8 110.2 124.9 144.5 170.1 193.9
EBIT 1 80.33 77.81 91.89 110.1 130.9 152.6
Operating Margin 8.43% 6.83% 6.99% 8.05% 7.62% 7.48%
Earnings before Tax (EBT) 1 29.52 47.57 60.55 70.86 99.02 154.9
Net income 1 18.38 36.21 41.75 62.06 82.16 130.1
Net margin 1.93% 3.18% 3.18% 4.54% 4.78% 6.37%
EPS 2 1.423 2.806 3.236 4.810 6.367 10.06
Free Cash Flow - - -12.69 -50.68 104.4 -26.09
FCF margin - - -0.97% -3.7% 6.08% -1.28%
FCF Conversion (EBITDA) - - - - 61.38% -
FCF Conversion (Net income) - - - - 127.12% -
Dividend per Share - - - 0.3333 0.2667 -
Announcement Date 03/09/19 03/09/19 04/12/20 01/11/21 22/08/22 03/11/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net Debt 1 309 288 237 274 212 207
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.761 x 2.618 x 1.896 x 1.898 x 1.248 x 1.07 x
Free Cash Flow - - -12.7 -50.7 104 -26.1
ROE (net income / shareholders' equity) - 18.9% 18.1% 22.2% 23.8% 34.1%
ROA (Net income/ Total Assets) - 6.95% 7.69% 8.6% 9.07% 9.14%
Assets 1 - 521.1 542.9 721.7 905.7 1,423
Book Value Per Share 2 13.40 16.20 19.50 23.90 29.50 34.10
Cash Flow per Share 2 1.480 2.060 2.800 1.120 2.220 1.580
Capex - - 24.9 74 3.15 43.3
Capex / Sales - - 1.89% 5.41% 0.18% 2.12%
Announcement Date 03/09/19 03/09/19 04/12/20 01/11/21 22/08/22 03/11/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. ACCENTMIC Stock
  4. Financials Accent Microcell Limited